ESC 365 - Plasma galectin-3 as a novel biomarker to cardiac events in very high-risk atherosclerotic cardiovascular disease population: a prospective study in an upper-middle-income country

Open Access

Plasma galectin-3 as a novel biomarker to cardiac events in very high-risk atherosclerotic cardiovascular disease population: a prospective study in an upper-middle-income country

Session: Poster session 3 - Understanding cardiovascular risk development: novel mechanisms (2)

Topic: Epidemiology, Prognosis, Outcome

Speaker: Mr F. Qhabibi (West Jakarta, ID)

Event: ESC Preventive Cardiology 2024

Congress Presentation

About the speaker

Mr Faqrizal Ria Qhabibi

West Jakarta (Indonesia)

0 follower

6 more presentations in this session

Discussants - Understanding cardiovascular risk development: novel mechanisms (2)

Circulating levels of amyloid-beta (1-40) peptide associate with cardiometabolic traits and risk for metabolic dysfunction

Speaker: Doctor D. Delialis (Athens, GR)

Effect of metabolic syndrome on mean platelet volume and relationship to extent of coronary artery disease.

Speaker: Doctor E. Sdogkos (Veria, GR)

Unlocking the mystery. Exploring the relationship between PFO anatomical features and the right to left shunt size

Speaker: Doctor D. Maritsa (London, GB)

Red cell distribution width - prognostic parameter that could be used in heart failure patients

Speaker: Miss A. Catana (Bucharest, RO)

Access the full session

Poster session 3 - Understanding cardiovascular risk development: novel mechanisms (2)

Speakers: Mr F. Qhabibi, Doctor D. Delialis, Doctor E. Sdogkos, Doctor D. Maritsa, Miss A. Catana

About the event

ESC Preventive Cardiology 2024

25 April - 27 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources